Type 1 diabetes, metabolic syndrome and cardiovascular risk

Metabolism: Clinical and Experimental

Volumn 63, Issue 2, 2014, Pages 181-187

  Chillarón, Juan J ^a   Flores Le Roux, Juana A ^b   Benaiges, David ^b   Pedro Botet, Juan ^b  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cardiovascular risk; Chronic complications; Metabolic syndrome; Type 1 diabetes

Indexed keywords

ADIPONECTIN; HEMOGLOBIN A1C; INSULIN; METFORMIN;

BODY MASS; CARDIOVASCULAR RISK; DYSLIPIDEMIA; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN TREATMENT; METABOLIC SYNDROME X; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVIEW; WEIGHT GAIN;

ADA; AMERICAN DIABETES ASSOCIATION; APO; APOLIPOPROTEIN; CARDIOVASCULAR RISK; CHRONIC COMPLICATIONS; DCCT; DIABETES CONTROL AND COMPLICATIONS TRIAL; EASD; EDIC; EGDR; EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS TRIAL; ESTIMATED GLUCOSE DISPOSAL RATE; EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES; HDL; HIGH-DENSITY LIPOPROTEINS; HOMA-IR; HOMEOSTASIS MODEL ASSESSMENT-INSULIN RESISTANCE; LDL; LOW-DENSITY LIPOPROTEINS; METABOLIC SYNDROME; T1DM; T2DM; TYPE 1 DIABETES; TYPE 1 DIABETES MELLITUS; TYPE 2 DIABETES MELLITUS;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; RISK ASSESSMENT; RISK FACTORS; WEIGHT GAIN;

EID: 84892679427     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.10.002     Document Type: Review

References (73)

1. J.J. Chillarón, A. Goday, and J. Pedro-Botet Metabolic syndrome, type 1 diabetes mellitus and insulin resistance Med Clin (Barc) 130 2008 466 471 (Pubitemid 351590272)
2. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
3. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2005 2643 2653
4. L.M. Thorn, C. Forsblom, and J. Fagerudd et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study) Diabetes Care 28 2005 2019 2024 (Pubitemid 41060978)
5. The Metascreen Writing Committee The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey Diabetes Care 29 2006 2701 2707
6. G. Pambianco, T. Costacou, and T.J. Orchard The prediction of major outcomes of type 1 diabetes: a 12 year prospective evaluation of three separate definitions of the metabolic syndrome, and their components and estimated glucose disposal rate: the Pittsburg Epidemiology of Diabetes Complications Study experience Diabetes Care 30 2007 1248 1254 (Pubitemid 46684655)
7. E.S. Kilpatrick, A.S. Rigby, and S.L. Atkin Insulin resistance, the metabolic syndrome, and complications risk in type 1 diabetes: "double diabetes" in the Diabetes Complications Trial Diabetes Care 30 2007 707 712 (Pubitemid 46354357)
8. B. Teupe, and K. Bergis Epidemiological evidence for "double diabetes" Lancet 337 1991 361 362
9. S.P. Laing, A.J. Swerdlow, and S.D. Slater et al. The British Diabetic Association Cohort Study II: cause-specific mortality in patients with insulin-treated diabetes mellitus Diabet Med 16 1999 466 471
10. G.M. Reaven The metabolic syndrome: requiescat in pace Clin Chem 51 2005 931 938 (Pubitemid 40740871)
11. V.P. Mäkinen, C. Forsblom, and L.M. Thorn et al. Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes Diabetes 57 2008 2480 2487
12. Y.W. Park, S. Zhu, and L. Palaniappan et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994 Arch Intern Med 163 2003 427 436 (Pubitemid 36241019)
13. J.J. Chillarón, J.A. Flores-Le-Roux, and A. Goday et al. Metabolic syndrome and type 1 diabetes mellitus: prevalence and associated factors Rev Esp Cardiol 63 2010 423 429
14. J. Reindel, E. Zander, and P. Heinke et al. The metabolic syndrome in patients with type 1 diabetes mellitus. Associations with cardiovascular risk factors and cardiovascular morbidity Herz 29 2004 463 469 (Pubitemid 39166102)
15. A. Ferreira-Hermosillo, G. Vargas-Ortega, and B. González-Virla et al. Prevalence of metabolic syndrome (MS) in patients with type 1 diabetes (DM1) Gac Med Mex 148 2012 137 143
16. J.J. Chillarón, M.P. Sales, and J.A. Flores Le-Roux et al. Atherogenic dyslipidemia in patients with type 1 diabetes mellitus Med Clin (Barc) 2013 10.1016/j.medcli.2013.03.016
17. T.M. Davis, D.G. Bruce, and W.A. Davis Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: the Fremantle Diabetes Study Diabetes Res Clin Pract 78 2007 412 417 (Pubitemid 350030323)
18. C.E. Santos, Y. Schrank, and R. Kupfer Critical analysis of WHO, IDF and NCEP criteria for metabolic syndrome among patients with type 1 diabetes mellitus Arq Bras Endocrinol Metabol 53 2009 1096 1102
19. M.S. Báez, A.V. Novik, and G.F. Alegría et al. Presence of metabolic syndrome among patients with type 1 diabetes mellitus Rev Med Chil 137 2009 888 893
20. D.P. Momesso, I. Bussade, and G.A. Lima et al. Body composition, metabolic syndrome and insulin resistance in type 1 diabetes mellitus Arq Bras Endocrinol Metabol 55 2011 189 193
21. K. Williams, J. Erbey, and D. Becker et al. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49 2000 626 632 (Pubitemid 30183752)
22. E. Bonora, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, and L. Zenari HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study Diabetes Care 25 2002 1135 1141 (Pubitemid 41071163)
23. J.J. Chillarón, A. Goday, and J.A. Flores-Le-Roux et al. Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes J Clin Endocrinol Metab 94 2009 3530 3534
24. C.M. Girgis, B.D. Scalley, and K.E. Park Utility of the estimated glucose disposal rate as a marker of microvascular complications in young adults with type 1 diabetes Diabetes Res Clin Pract 96 2012 e70 e72
25. T.J. Orchard, J.C. Olson, and J.R. Erbey et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study Diabetes Care 26 2003 1374 1379 (Pubitemid 36929165)
26. J.C. Olson, J.R. Erbey, and K.Y. Forrest et al. Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes Metabolism 51 2002 248 254 (Pubitemid 34168241)
27. J. Yip, M.B. Mattock, A. Morocutti, M. Sethi, R. Trevisan, and G. Viberti Insulin resistance in insulin-dependent diabetic patients with microalbuminuria Lancet 342 1993 883 887 (Pubitemid 23291590)
28. J.C. Olson, J.R. Erbey, and K.V. Williams et al. Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in type 1 diabetes Ann Epidemiol 12 2002 331 337 (Pubitemid 34621493)
29. T. Yatagai, S. Nagasaka, and A. Taniguchi et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus Metabolism 52 2003 1274 1278 (Pubitemid 37351094)
30. M. Ryo, T. Nakamura, and S. Kihara et al. Adiponectin as a biomarker of the metabolic syndrome Circ J 68 2004 975 981 (Pubitemid 39540124)
31. A. Jorsal, L. Tarnow, and J. Frystyk et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type 1 diabetes and diabetic nephropathy Kidney Int 74 2008 649 654
32. J. Chudeck, M. Adamczak, and H. Karkoszka et al. Plasma adiponectin concentration before and after successful kidney transplantation Transplant Proc 35 2003 2186 2189 (Pubitemid 37194359)
33. S.L. Prior, T.S. Tang, G.V. Gill, S.C. Bain, and J.W. Stephens Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk "Golden Years" type 1 diabetes mellitus cohort Metabolism 60 2011 173 179
34. R.I. Pereira, J.K. Snell-Bergeon, and C. Erickson et al. Adiponectin dysregulation and insulin resistance in type 1 diabetes J Clin Endocrinol Metab 97 2012 E642 E647
35. K. Blaslov, T. Bulum, K. Zibar, and L. Duvnjak Relationship between adiponectin level, insulin sensitivity, and metabolic syndrome in type 1 diabetic patients Int J Endocrinol 2013 2013 535906 10.1155/2013/535906
36. K.C. Verbeeten, C.E. Elks, D. Daneman, and K.K. Ong Association between childhood obesity and subsequent type 1 diabetes: a systematic review and meta-analysis Diabet Med 28 2011 10 18
37. B. Conway, R.G. Miller, and T. Costacou et al. Temporal patterns in overweight and obesity in type 1 diabetes Diabet Med 27 2010 398 404
38. C. Ogden, S.Z. Yanovski, and M.D. Carroll et al. The epidemiology of obesity Gastroenterology 132 2007 2087 2102 (Pubitemid 46693751)
39. M. van Vliet, J.C. Van der Heyden, and M. Diamant et al. Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk J Pediatr 156 2010 923 929
40. P.E. Miguel-Soca, and I. Corella-del Toro Risk lipoprotein profile in patients with type 1 diabetes mellitus An Pediatr (Barc) 2013 10.1016/j.anpedi.2013. 02.002
41. E.O. Melin, M. Thunander, R. Svensson, M. Landin-Olsson, and H.O. Thulesius Depression, obesity, and smoking were independently associated with inadequate glycemic control in patients with type 1 diabetes Eur J Endocrinol 168 2013 861 869
42. J.Q. Purnell, B. Zinman, and J.D. Brunzell et al. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study Circulation 127 2013 180 187
43. D. Vestberg, A. Rosengren, M. Olsson, S. Gudbjörnsdottir, A.M. Svensson, and M. Lind Relationship between overweight and obesity with hospitalization for heart failure in 20,985 patients with type 1 diabetes: a population-based study from the Swedish national diabetes registry Diabetes Care 36 2013 2857 2861
44. P.J. Nielsen, A.R. Hafdahl, and V.S. Conn et al. Meta-analysis of the effect of exercise interventions on fitness outcomes among adults with type 1 and type 2 diabetes Diabetes Res Clin Pract 74 2006 111 120 (Pubitemid 44764908)
45. V.S. Conn, A.R. Hafdahl, and J.W. Lemaster et al. Meta-analysis of health behavior change interventions in type 1 diabetes Am J Health Behav 32 2008 315 329
46. J.D. Brunzell, M. Davidson, and C.D. Furberg et al. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation J Am Coll Cardiol 51 2008 1512 1524 (Pubitemid 351470037)
47. J. Millán Núñez-Cortés, J. Pedro-Botet Montoya, and Sala X. Pintó Residual vascular risk: recommendations of the Spanish Initiative for the Reduction of Residual Risk Med Clin (Barc) 135 2010 165 171
48. A.D. Mooradian, M.J. Haas, and N.C. Wong Transcriptional control of apolipoprotein A-I gene expression in diabetes Diabetes 53 2004 513 520 (Pubitemid 38270617)
49. A. Pérez, A.M. Wägner, and G. Carreras et al. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control Arch Intern Med 160 2000 2756 2762
50. M.E. Molitch, D. Rupp, and M. Carnethon Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes Diabetes Care 29 2006 78 82 (Pubitemid 44033435)
51. B. Vergès Lipid disorders in type 1 diabetes Diabetes Metab 35 2009 353 360
52. J.M. Sosenko, J.L. Breslow, and O.S. Miettinen et al. Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients N Engl J Med 302 1980 650 654 (Pubitemid 10132147)
53. The DCCT Research Group Lipid and lipoprotein levels in patients with IDDM: Diabetes Control and Complications Trial experience Diabetes Care 15 1992 886 894
54. The seventh report of the Joint National Committee in Prevention: Detection, Evaluation, and Treatment of High Blood Pressure 2004 National Heart, Lung, and Blood Institute, National Institutes of Health, US Dept of Health and Human Services Bethesda, MD
55. C. Arauz-Pacheco, M.A. Parrott, and P. Raskin The treatment of hypertension in adult patients with diabetes Diabetes Care 25 2002 134 147
56. J.J. Chillarón, M.P. Sales, and J.A. Flores-Le-Roux et al. Insulin resistance and hypertension in patients with type 1 diabetes J Diabetes Complications 25 2011 232 236
57. D.M. Maahs, G.L. Kinney, and P. Wadwa et al. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population Diabetes Care 28 2005 301 306 (Pubitemid 40170930)
58. F. Collado-Mesa, H.M. Colhoun, and L.K. Stevens et al. Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM Complications Study Diabet Med 16 1999 41 48
59. S.S. Soedamah-Muthu, H.M. Colhoun, and H. Abrahamian et al. Trends in hypertension management in type I diabetes across Europe, 1989/1990-1997/1999 Diabetologia 45 2002 1362 1371 (Pubitemid 35244888)
60. D.I.A.M.A.N.T.E. Estudio Renal involvement in type 1 (IDDM) diabetes in Spain Diabetes Res Clin Pract 38 1997 129 137
61. P.L. De Pablos-Velasco, F. Martínez-Martín, and J.A. Aguilar Prevalence of hypertension in IDDM patients in the Northern Grand Canary Island, according to the WHO/ISH and JNC-V/ADA criteria Diabetes Res Clin Pract 38 1997 191 197 (Pubitemid 28104385)
62. American Diabetes Association Standards of medical care in diabetes - 2013 Diabetes Care 36 Suppl 1 2013 S11 S66
63. The Task Force on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, prediabetes and cardiovascular diseases: executive summary Eur Heart J 28 2007 88 136
64. C. Pehmøller, N. Brandt, and J.B. Birk et al. Exercise alleviates lipid-induced insulin resistance in human skeletal muscle-signaling interaction at the level of TBC1 domain family member 4 Diabetes 61 2012 2743 2752
65. R. Mackenzie, N. Maxwell, and P. Castle et al. Intermittent exercise with and without hypoxia improves insulin sensitivity in individuals with type 2 diabetes J Clin Endocrinol Metab 97 2012 E546 E555
66. S. Vella, L. Buetow, and P. Royle et al. The use of metformin in type 1 diabetes: a systematic review of efficacy Diabetologia 53 2010 809 820
67. T. Teranishi, T. Ohara, and K. Maeda et al. Effects of pioglitazone and metformin on intracellular content in liver and skeletal muscle of individuals with type 2 diabetes mellitus Metabolism 56 2007 1418 1424 (Pubitemid 47404606)
68. R. Bhat, A. Bhansali, and S. Bhadada et al. Effect of pioglitazone therapy in lean type 1 diabetes mellitus Diabetes Res Clin Pract 78 2007 349 354 (Pubitemid 350030318)
69. V. Zdravkovic, J.K. Hamilton, and D. Daneman et al. Pioglitazone as adjunctive therapy in adolescents with type 1 diabetes J Pediatr 149 2006 845 849
70. E.Y. Choe, H.J. Wang, and O. Kwon et al. Variants of the adiponectin gene and diabetic microvascular complications in patients with type 2 diabetes Metabolism 62 2013 677 685
71. J. Ma, A. Mollsten, and H. Falhammar et al. Genetic association analysis of the adiponectin polymorphism in type 1 diabetes with and without diabetic nephropathy J Diabetes Complications 21 2007 28 33 (Pubitemid 44960846)
72. A.M. Rosenfalck, T. Almdal, L. Viggers, S. Madsbad, and J. Hilsted A low-fat diet improves peripheral insulin sensitivity in patients with type 1 diabetes Diabet Med 23 2006 384 392
73. A. Leone, E. Di Gennaro, F. Bruzzese, A. Avallone, and A. Budillon New perspective for an old antidiabetic drug: Metformin as anticancer agent Cancer Treat Res 159 2014 355 376